Get started
Author

André F. Carvalho

Observed names: Andre Carvalho, Andre F. Carvalho, André Carvalho
ORCID: 0000-0002-4021-8675
Observed ORCID: 0000-0002-4021-8675
OpenAlex ID: A5101497781
Eotaxin, an Endogenous Cognitive Deteriorating Chemokine (ECDC), Is a Major Contributor to Cognitive Decline in Normal People and to Executive, Memory, and Sustained Attention Deficits, Formal Thought Disorders, and Psychopathology in Schizophrenia Patients
2018 · Sunee Sirivichayakul, Buranee Kanchanatawan, et al. · Neurotoxicity Research · 77
Generalized Anxiety Disorder (GAD) and Comorbid Major Depression with GAD Are Characterized by Enhanced Nitro-oxidative Stress, Increased Lipid Peroxidation, and Lowered Lipid-Associated Antioxidant Defenses
2018 · Michael Maes, Kamila Landucci Bonifacio, et al. · Neurotoxicity Research · 76
Frailty and incident depression in community‐dwelling older people: results from the ELSA study
2017 · Nicola Veronese, Marco Solmi, et al. · International Journal of Geriatric Psychiatry · 61
Immune Aberrations in Obsessive-Compulsive Disorder: a Systematic Review and Meta-analysis
2018 · Theodore D. Cosco, Toby Pillinger, et al. · Molecular Neurobiology · 59
Increased Levels of Plasma Tumor Necrosis Factor-α Mediate Schizophrenia Symptom Dimensions and Neurocognitive Impairments and Are Inversely Associated with Natural IgM Directed to Malondialdehyde and Paraoxonase 1 Activity
2020 · Michael Maes, Sunee Sirivichayakul, et al. · Molecular Neurobiology · 56
Lowered Antioxidant Defenses and Increased Oxidative Toxicity Are Hallmarks of Deficit Schizophrenia: a Nomothetic Network Psychiatry Approach
2020 · Michael Maes, Sunee Sirivichayakul, et al. · Molecular Neurobiology · 55
Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway
2017 · Buranee Kanchanatawan, Sunee Sirivichayakul, et al. · Metabolic Brain Disease · 52
Increased Serum Immunoglobulin Responses to Gut Commensal Gram-Negative Bacteria in Unipolar Major Depression and Bipolar Disorder Type 1, Especially When Melancholia Is Present
2019 · Denitsa Simeonova, Drozdstoy Stoyanov, et al. · Neurotoxicity Research · 51
Recognizing the Leaky Gut as a Trans-diagnostic Target for Neuroimmune Disorders Using Clinical Chemistry and Molecular Immunology Assays
2018 · Denitsa Simeonova, Mariya Ivanovska, et al. · Current Topics in Medicinal Chemistry · 48
Activated neuro-oxidative and neuro-nitrosative pathways at the end of term are associated with inflammation and physio-somatic and depression symptoms, while predicting outcome characteristics in mother and baby
2017 · Chutima Roomruangwong, Decio Sabbatini Barbosa, et al. · Journal of Affective Disorders · 34
Increased Oxidative Stress Toxicity and Lowered Antioxidant Defenses in Temporal Lobe Epilepsy and Mesial Temporal Sclerosis: Associations with Psychiatric Comorbidities
2020 · Michael Maes, Thitiporn Supasitthumrong, et al. · Molecular Neurobiology · 30
PDF
Chronic fatigue and fibromyalgia symptoms are key components of deficit schizophrenia and are strongly associated with activated immune-inflammatory pathways
2020 · Abbas F. Almulla, Hussein Kadhem Al-Hakeim, et al. · Schizophrenia Research · 25
PDF
The role of immune and oxidative pathways in menstrual cycle associated depressive, physio-somatic, breast and anxiety symptoms: Modulation by sex hormones
2020 · Chutima Roomruangwong, Andressa Keiko Matsumoto, et al. · Journal of Psychosomatic Research · 25
PDF
In Schizophrenia, Psychomotor Retardation is Associated with Executive and Memory Impairments, Negative and Psychotic Symptoms, Neurotoxic Immune Products and Lower Natural IgM to Malondialdehyde
2019 · Michael Maes, Sunee Sirivichayakul, et al. · Preprints.org · 12
PDF
The gynecologic tumor risk related to GLP-1 receptor agonists and SGLT2 inhibitors use: a network meta-analysis of 91 randomized controlled trials
2025 · Ping-Tao Tseng, Bing-Yan Zeng, et al. · Journal of Hematology & Oncology · 7
PDF
Correction to: Increased Levels of Plasma Tumor Necrosis Factor-α Mediate Schizophrenia Symptom Dimensions and Neurocognitive Impairments and Are Inversely Associated with Natural IgM Directed to Malondialdehyde and Paraoxonase 1 Activity
2022 · Michael Maes, Sunee Sirivichayakul, et al. · Molecular Neurobiology · 1
PDF
Increased Levels of Plasma Tumor Necrosis Factor-α Mediate Schizophrenia Symptom Dimensions and Neurocognitive Impairments and Are Inversely Associated with Natural IgM and Paraoxonase 1 Activity
2019 · Michael Maes, Sunee Sirivichayakul, et al. · Preprints.org · 1
In Schizophrenia, Low Natural IgM Antibody Titers to Oxidative Specific Epitopes and Higher IgM Responses to Nitrated and Nitrosylated Proteins Strongly Predict Negative Symptoms, Neurocognitive Impairments and the Deficit Syndrome
2018 · Michael Maes, Buranee Kanchanatawan, et al. · Preprints.org · 1
PDF
Neuropsychiatric Inventory--Brazilian Version
2008 · Ana Luiza Camozzato, Renata Kochhann, et al. · PsycTESTS Dataset
Works count: 20
Citation count: 671
H-index: 13
I10-index: 14
Year
Topic
Type